Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Apr 2610:00 AM EDT
-11:00 AM EDT
The Target Test Prep course represents a quantum leap forward in GMAT preparation, a radical reinterpretation of the way that students should study. Try before you buy with a 5-day, full-access trial of the course for FREE!
Apr 2601:30 AM EDT
-02:30 AM EDT
Learn how Keshav, a Chartered Accountant, scored an impressive 705 on GMAT in just 30 days with GMATWhiz's expert guidance. In this video, he shares preparation tips and strategies that worked for him, including the mock, time management, and more.
Apr 2711:00 AM EDT
-12:00 PM EDT
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors
Apr 2808:00 AM PDT
-11:00 AM PDT
Whether you are just beginning your MBA journey or fine-tuning your path to a 700+ score, GMAT Day is designed to give you a competitive edge.
May 0111:00 AM PDT
-12:00 PM PDT
Free- full-length test + 15 concept videos + 150+ short videos + study plan!
31 Jan 2022, 06:00
Kudos
Bookmarks
A
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
25%
(medium)
Question Stats:
79% (01:36) correct
21%
(02:02)
wrong
based on 370
sessions
History
Date
Time
Result
Not Attempted Yet
Newspaper editorial: Many pharmaceutical companies develop “me too” drugs, drugs designed to duplicate, more or less, the effect of another company’s product that is already on the market. Some critics object that such development constitutes an unnecessary, redundant use of resources that provides no new benefits to consumers. However, the entry of “me too” drugs into the market can result in a price reduction for the drugs they resemble. Therefore, “me too” drugs can indeed benefit consumers.
Which one of the following, if true, most strengthens the editorial’s argument?
(A) Some “me too” drugs turn out to be more effective than the drugs they were designed to imitate.
(B) If “me too” drugs were prohibited, more money would be available for the development of innovative drugs.
(C) Pharmaceutical companies often make more money on a “me too” drug than on an original drug.
(D) If all pharmaceutical companies developed “me too” drugs, fewer innovative drugs would be developed.
(E) Some pharmaceutical companies lose money on the development of innovative drugs because of the development by other companies of “me too” drugs.
Which one of the following, if true, most strengthens the editorial’s argument?
(A) Some “me too” drugs turn out to be more effective than the drugs they were designed to imitate.
(B) If “me too” drugs were prohibited, more money would be available for the development of innovative drugs.
(C) Pharmaceutical companies often make more money on a “me too” drug than on an original drug.
(D) If all pharmaceutical companies developed “me too” drugs, fewer innovative drugs would be developed.
(E) Some pharmaceutical companies lose money on the development of innovative drugs because of the development by other companies of “me too” drugs.
11 Feb 2022, 18:35
Kudos
Bookmarks
Me2 --> $ drop --> cons. benefit
goal: to strengthen
a) Me2 > effective than orig. ---> consumer gets more effective drug than what is available now (Most likely answer)
b) No Me2 --> >$ for innov. -- Me2 is sucking money and not allowing innovation --> weakens --> ELIMINATE
(C) PHARM. earn more $ on Me2 than orig. (Good for them --> no rel. with consumer benefit) (ELIMINATE)
(D) Me2 is a likely Innov. killer (Poor consumers) --> ELIMINATE.
(E) Me2 is making some pharm loose $ (sorry for those companies, but no relation with consumer here) --> ELIMINATE
Hence A is the answer.
goal: to strengthen
a) Me2 > effective than orig. ---> consumer gets more effective drug than what is available now (Most likely answer)
b) No Me2 --> >$ for innov. -- Me2 is sucking money and not allowing innovation --> weakens --> ELIMINATE
(C) PHARM. earn more $ on Me2 than orig. (Good for them --> no rel. with consumer benefit) (ELIMINATE)
(D) Me2 is a likely Innov. killer (Poor consumers) --> ELIMINATE.
(E) Me2 is making some pharm loose $ (sorry for those companies, but no relation with consumer here) --> ELIMINATE
Hence A is the answer.
13 Feb 2022, 10:44
Kudos
Bookmarks
Argument:
- "Me too" drugs are drugs that have all most the same effect as existing drugs on the market
- Since the effects are the same, some critics object that the development of such drugs is unnecessary. Why? Because there is no new benefit brought to consumers
- The author however believes that there is some benefit: These drugs help in reducing the price of the drugs thereby providing monetary benefits to the consumer
Conclusion: "Me too" drugs can benefit consumers
Question: Strengthen
Correct Choice: (A)
- "Me too" drugs are drugs that have all most the same effect as existing drugs on the market
- Since the effects are the same, some critics object that the development of such drugs is unnecessary. Why? Because there is no new benefit brought to consumers
- The author however believes that there is some benefit: These drugs help in reducing the price of the drugs thereby providing monetary benefits to the consumer
Conclusion: "Me too" drugs can benefit consumers
Question: Strengthen
Quote:
Correct: Clearly this choice states that "me too" drugs a beneficial to the consumers. By being more effective, the consumers are definitely going to benefit from using these drugs.
Quote:
Irrelevant. We want to prove that "me too" drugs are beneficial to consumers. By stating the alternate use of money - had mee to drugs not been in the picture - doesn't help us prove our point. If anything, this choice slightly weakens the argument by showing how the money would have been invested for something else that could be better: Innovative drugs.
Quote:
Irrelevant. We want to show how "me too" drugs benefit the customers NOT the companies.
Quote:
Weaken. I believe that this choice has a negative impact on our argument. By stating a situation in which "me too" drugs leads to fewer innovative drugs, this choice is proving the ill effects of using/producing "me too" drugs
Quote:
Out of Scope. This choice talks about how certain companies are at a disadvantage due to "me too" drugs. Again, what we care about is the benefit brought to the customers.
Correct Choice: (A)
